Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Adler

Showing results (601-610 of 830) with videos related to

Pageof 83
Sort By:
Neurology|August 1, 1997
Ropinirole for the treatment of early Parkinson's disease. The Ropinirole Study GroupC H Adler, K D Sethi, R A Hauser, et al.
Dysphagia|August 22, 2025
Alpha-Synuclein Lesions in the Peripheral Nervous System of the Larynx in Parkinson's DiseaseLiancai Mu, Jingming Chen, Themba Nyirenda, et al.
Acta Neuropathologica Communications|June 22, 2022
Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body diseaseSara Hall, Christina D Orrù, Geidy E Serrano, et al.
Biomarkers in Medicine|March 30, 2017
The Systemic Synuclein Sampling Study: toward a biomarker for Parkinson's diseaseNaomi P Visanji, Brit Mollenhauer, Thomas G Beach, et al.
Innovations in Clinical Neuroscience|January 2, 2023
Olfactory Dysfunction in Incidental Lewy Body Disease and Parkinson's Disease: An UpdateShemonti Hasan, Charles H Adler, Nan Zhang, et al.
Clinical and Experimental Medical Sciences|October 18, 2014
Prevalence of Hippocampal Sclerosis in a Clinicopathologically Characterized CohortMichael Malek-Ahmadi, Vickram Kahlon, Charles H Adler, et al.
Neurological Research|August 15, 2012
Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson's disease subjectsChera L Maarouf, Thomas G Beach, Charles H Adler, et al.
Acta Biomaterialia|June 29, 2024
Flexural rigidity of hawkmoth antennae depends on the bending directionAdam Puchalski, Zoë McCarthy, Alexandre Varaschin Palaoro, et al.
Lipids|March 1, 1982
A comparison of the biological properties of androst-5-en-3 beta-ol, a series of (20R)-n-alkylpregn-5-en-3 beta-ols and 21-isopentylcholesterol with those of cholesterolW R Nes, J H Adler, J T Billheimer, et al.
Journal of Clinical and Experimental Neuropsychology|February 9, 2022
An initial exploration of the convergent and ecological validity of the UDS 3.0 neuropsychological battery in Parkinson's DiseaseRoShunna Lea, Jared F Benge, Charles H Adler, et al.
Pageof 83

Showing results (601-610 of 830) with videos related to

Sort By:
Pageof 83
Neurology|August 1, 1997
Ropinirole for the treatment of early Parkinson's disease. The Ropinirole Study GroupC H Adler, K D Sethi, R A Hauser, et al.
Dysphagia|August 22, 2025
Alpha-Synuclein Lesions in the Peripheral Nervous System of the Larynx in Parkinson's DiseaseLiancai Mu, Jingming Chen, Themba Nyirenda, et al.
Acta Neuropathologica Communications|June 22, 2022
Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body diseaseSara Hall, Christina D Orrù, Geidy E Serrano, et al.
Biomarkers in Medicine|March 30, 2017
The Systemic Synuclein Sampling Study: toward a biomarker for Parkinson's diseaseNaomi P Visanji, Brit Mollenhauer, Thomas G Beach, et al.
Innovations in Clinical Neuroscience|January 2, 2023
Olfactory Dysfunction in Incidental Lewy Body Disease and Parkinson's Disease: An UpdateShemonti Hasan, Charles H Adler, Nan Zhang, et al.
Clinical and Experimental Medical Sciences|October 18, 2014
Prevalence of Hippocampal Sclerosis in a Clinicopathologically Characterized CohortMichael Malek-Ahmadi, Vickram Kahlon, Charles H Adler, et al.
Neurological Research|August 15, 2012
Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson's disease subjectsChera L Maarouf, Thomas G Beach, Charles H Adler, et al.
Acta Biomaterialia|June 29, 2024
Flexural rigidity of hawkmoth antennae depends on the bending directionAdam Puchalski, Zoë McCarthy, Alexandre Varaschin Palaoro, et al.
Lipids|March 1, 1982
A comparison of the biological properties of androst-5-en-3 beta-ol, a series of (20R)-n-alkylpregn-5-en-3 beta-ols and 21-isopentylcholesterol with those of cholesterolW R Nes, J H Adler, J T Billheimer, et al.
Journal of Clinical and Experimental Neuropsychology|February 9, 2022
An initial exploration of the convergent and ecological validity of the UDS 3.0 neuropsychological battery in Parkinson's DiseaseRoShunna Lea, Jared F Benge, Charles H Adler, et al.
Pageof 83